Met life stock price trading algorithms identify MetLife

Trading algorithms identify MetLife stock price above the $67 threshold as maintaining upward bias until macroeconomic triggers shift market flows. Some better-ranked stocks in the broader finance space are Evercore Inc. EVR, Heritage Insurance Holdings Inc. HRTG and Acadian Asset Management Inc. AAMI, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here . Several other institutional investors have also made changes to their positions in the company. North Capital Inc. acquired a new stake in MetLife in the first quarter valued at approximately $26,000. Motco lifted its stake in shares of MetLife by 105.5% in the 1st quarter. Motco now owns 413 shares of the financial services provider's stock valued at $33,000 after purchasing an additional 212 shares during the last quarter. Abound Wealth Management lifted its stake in shares of MetLife by 652.3% in the 2nd quarter. Abound Wealth Management now owns 489 shares of the financial services provider's stock valued at $39,000 after purchasing an additional 424 shares during the last quarter. Legend Financial Advisors Inc. acquired a new stake in shares of MetLife in the 2nd quarter valued at $40,000. Finally, WPG Advisers LLC acquired a new stake in shares of MetLife in the 1st quarter valued at $46,000. 94.99% of the stock is currently owned by institutional investors and hedge funds. Get MetLife alerts: Sign Up MetLife Trading Down 0.4% MetLife stock opened at $82.06 on Thursday. The business has a 50 day moving average price of $78.96 and a two-hundred day moving average price of $78.20. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. The stock has a market cap of $54.57 billion, a price-to-earnings ratio of 13.91, a price-to-earnings-growth ratio of 0.74 and a beta of 0.86. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. MarketBeat Week in Review – 8/21 - 8/25 MetLife ( NYSE:MET - Get Free Report ) last issued its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.28 earnings per share. As a group, equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year. MetLife Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th were paid a $0.5675 dividend. The ex-dividend date was Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. MetLife's dividend payout ratio is currently 38.47%. Wall Street Analyst Weigh In This Insurance Giant Looks Ready For A Breakout A number of analysts have weighed in on MET shares. JPMorgan Chase & Co. boosted their price target on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 8th. UBS Group reduced their target price on MetLife from $94.00 to $91.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Jefferies Financial Group boosted their target price on MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a report on Monday, August 11th. Wells Fargo & Company restated an "overweight" rating and issued a $97.00 price objective (up from $94.00) on shares of MetLife in a research note on Thursday, July 10th. Finally, Cowen restated a "buy" rating on shares of MetLife in a research note on Friday, August 22nd. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $94.64. Check Out Our Latest Analysis on MetLife MetLife Company Profile ( Free Report ) MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. Featured Articles Five stocks we like better than MetLife Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio Datavault AI: The New AI Contender Backed by Big Funding The Risks of Owning Bonds CoreWeave: Why the New King of AI Infrastructure Has Room to Run What Are Dividend Champions? How to Invest in the Champions Top 3 Dividend Achievers for October: High Yields, Growth Ahead This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Should You Invest $1,000 in MetLife Right Now? Before you consider MetLife, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list. While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here The Best High-Yield Dividend Stocks for 2025 Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps. Get This Free Report Market strategists highlight the $66.90 MetLife stock price support level, a key point traders watch for potential rebounds in the financial and insurance sector.